FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of February 23, 2027Application supported by positive results from Phase ...

FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of February 23, 2027Application supported by positive results from Phase 2 open-label INTEGUMENT-INFANT study and Phase 1 open-l ...

In the monsoon due to humidity , sweating and moisture disrupts the natural balance of the scalp. Monsoon comes with several ...

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovation in immuno-dermatology, today announced that Christopher "Chris” ...

Humidity during the monsoon creates the perfect conditions for Malassezia fungus to thrive, causing dandruff and itchy scalp.

In the INTEGUMENT-INFANT trial, 34.4% of patients achieved vIGA-AD success and 58.3% reached EASI-75 at week 4.

(Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that the U.S. Food and Drug Administration (FDA) has ...

The monsoon changes the way India’s scalp behaves. The season brings relief from harsh summer heat, but it also introduces ...

Minoxidil is very popular and often used for treating hair loss for a reason, as it works for many. However, as with any drug, it has its side effects. They are mostly non-severe and treatable, but ...

Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of ...

HT Health Talk: Is the rainy season ruining your skin and hair? Dr Shireen Furtado of Aster CMI Bengaluru reveals what you ...

FACT: Available evidence suggests that acemannan and other compounds in aloe vera can influence immune cells and exhibit anti ...